Alector Inc Net Income per Employee (ALEC), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Alector Inc   (NASDAQ: ALEC)
 

Alector Inc Net Income per Employee

ALEC's Quarterly Results, Trends, Rankings, Statistics
Alector Inc recorded a cumulative net loss of $-125 million during 12 month ending in the first quarter 2026.
The Healthcare sector has seen employees of 93 other companies achieving higher income per employee. While Alector Inc 's total ranking has deteriorated compared to the previous quarter from 2092 to 3749.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALEC Net Income per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -1,217,359 -1,387,660 -1,045,981 -1,119,311 -1,198,456
ALEC's Total Ranking # 3749 # 2092 # 3145 # 3065 # 3220
Seq. Net Income Change - - - - -

ALEC Company Profile >> Back to ALEC Efficiency Comparisons >> Compare ALEC Net Income per Employee to its Competitors

ALEC Net Income per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 94
Healthcare Sector # 640
Overall Market # 3749

Net Income per Employee Statistics
High Average Low
$ 351,990 $ -1,160,099 $ -2,060,204
(Jun 30 2022)   (Jun 30 2021)




  News about Alector Inc Income per employee

South San Francisco, Calif, Jan 19, 2024 - In an impressive move for the field of immuno-neurology, Alector, Inc (Nasdaq: ALEC), a leading clinical-stage biotechnology company, has successfully completed its underwritten public offering of shares of its common stock The offering saw Alector sell an impressive 10,869,566 shares of its common stock, signifying the company's steadfast commitment to advancing breakthrough treatments in this innovative sector

South San Francisco, Calif., Jan. 19, 2024 - In an impressive move for the field of immuno-neurology, Alector, Inc. (Nasdaq: ALEC), a leading clinical-stage biotechnology company, has successfully completed its underwritten public offering of shares of its common stock. The offering saw Alector sell an impressive 10,869,566 shares of its common stock, signifying the company s steadfast commitment to advancing breakthrough treatments in this innovative sector.
Alector s groundbreaking work revolves around harnessing the power of the immune system to combat neurological disorders. By leveraging the potential of immuno-neurology, Alector aims to develop effective therapeutics to address the unmet medical needs of patients suffering from devastating conditions such as Alzheimer s disease and frontotemporal dementia.




Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026


Date modified: 2026-08-29T17:40:56+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.